1H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ (DiRu-1)

Primasova, Hedvika; Paul, Lydia; Diserens, Gaëlle; Primasová, Ester; Vermathen, Peter; Vermathen, Martina; Furrer, Julien (2019). 1H HR-MAS NMR-Based Metabolomics of Cancer Cells in Response to Treatment with the Diruthenium Trithiolato Complex [(p-MeC6H4iPr)2Ru2(SC6H4-p-But)3]+ (DiRu-1). Metabolites, 9(7), p. 146. MDPI 10.3390/metabo9070146

[img]
Preview
Text
metabolites-09-00146.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (3MB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

08 Faculty of Science > Departement of Chemistry and Biochemistry
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Forschungsbereich Pavillon 52 > Abt. Magnetresonanz-Spektroskopie und Methodologie, AMSM
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR)

UniBE Contributor:

Primasova, Hedvika; Paul, Lydia; Diserens, Gaëlle; Vermathen, Peter; Vermathen, Martina and Furrer, Julien

Subjects:

500 Science > 570 Life sciences; biology
500 Science > 540 Chemistry
600 Technology > 610 Medicine & health

ISSN:

2218-1989

Publisher:

MDPI

Language:

English

Submitter:

Hedvika Primasova

Date Deposited:

31 Jul 2019 15:00

Last Modified:

22 Oct 2019 16:35

Publisher DOI:

10.3390/metabo9070146

Related URLs:

Uncontrolled Keywords:

ovarian cancer; cytotoxicity; ruthenium complex; HR-MAS NMR; NMR metabolomics; A2780; cis-Pt resistant; metal-based drugs

BORIS DOI:

10.7892/boris.132087

URI:

https://boris.unibe.ch/id/eprint/132087

Actions (login required)

Edit item Edit item
Provide Feedback